Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 573

1.

Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification.

Malhotra R, Olsson H.

Expert Rev Respir Med. 2015 Jan 14:1-7. [Epub ahead of print]

PMID:
25586213
[PubMed - as supplied by publisher]
2.

Tobacco and Alcohol in Relation to Male Breast Cancer: An Analysis of the Male Breast Cancer Pooling Project Consortium.

Cook MB, Guenel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsson H, Parisi D, Petridou ET, Riboli E, Sesso HD, Swerdlow A, Thomas DB, Willett WC, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 2014 Dec 16. pii: cebp.1009.2014. [Epub ahead of print]

PMID:
25515550
[PubMed - as supplied by publisher]
3.

Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma.

Aoude LG, Pritchard AL, Robles-Espinoza CD, Wadt K, Harland M, Choi J, Gartside M, Quesada V, Johansson P, Palmer JM, Ramsay AJ, Zhang X, Jones K, Symmons J, Holland EA, Schmid H, Bonazzi V, Woods S, Dutton-Regester K, Stark MS, Snowden H, van Doorn R, Montgomery GW, Martin NG, Keane TM, López-Otín C, Gerdes AM, Olsson H, Ingvar C, Borg A, Gruis NA, Trent JM, Jönsson G, Bishop DT, Mann GJ, Newton-Bishop JA, Brown KM, Adams DJ, Hayward NK.

J Natl Cancer Inst. 2014 Dec 13;107(2). pii: dju408. doi: 10.1093/jnci/dju408. Print 2015 Feb.

PMID:
25505254
[PubMed - in process]
4.

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.

Candido Dos Reis FJ, Song H, Goode EL, Cunningham JM, Fridley BL, Larson MC, Alsop K, Dicks E, Harrington P, Ramus SJ, de Fazio A, Mitchell G, Fereday S, Bolton KL, Gourley C, Michie C, Karlan BY, Lester J, Walsh C, Cass I, Olsson H, Gore M, Benitez J, Garcia MJ, Andrulis IL, Mulligan AM, Glendon G, Blanco I, Lazaro C, Whittemore AS, McGuire V, Sieh W, Montagna M, Alducci E, Sadetzki S, Chetrit A, Kwong A, Kjaer SK, Jensen A, Hogdall E, Neuhausen SL, Nussbaum RL, Daly M, Greene MH, Mai PL, Loud JT, Moysich KB, Toland AE, Lambrechts D, Ellis S, Frost D, Brenton JD, Tischkowitz M, Easton DF, Antoniou AC, Chenevix-Trench G, Gayther SA, Bowtell DD, Pharoah PD.

Clin Cancer Res. 2014 Nov 14. pii: clincanres.2497.2014. [Epub ahead of print]

PMID:
25398451
[PubMed - as supplied by publisher]
5.

Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer.

Aaltonen KE, Rosendahl AH, Olsson H, Malmström P, Hartman L, Fernö M.

BMC Cancer. 2014 Nov 3;14:794. doi: 10.1186/1471-2407-14-794.

PMID:
25362932
[PubMed - in process]
Free PMC Article
6.

Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay.

Welinder C, Jönsson GB, Ingvar C, Lundgren L, Baldetorp B, Olsson H, Breslin T, Rezeli M, Jansson B, Fehniger TE, Laurell T, Wieslander E, Pawlowski K, Marko-Varga G.

PLoS One. 2014 Oct 21;9(10):e110804. doi: 10.1371/journal.pone.0110804. eCollection 2014.

PMID:
25333933
[PubMed - in process]
Free PMC Article
7.

Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort.

Ellberg C, Jernström H, Broberg P, Borg Å, Olsson H.

Genes Chromosomes Cancer. 2015 Jan;54(1):39-50. doi: 10.1002/gcc.22217. Epub 2014 Sep 23.

PMID:
25251729
[PubMed - in process]
8.

The effect on melanoma risk of genes previously associated with telomere length.

Iles MM, Bishop DT, Taylor JC, Hayward NK, Brossard M, Cust AE, Dunning AM, Lee JE, Moses EK, Akslen LA; AMFS Investigators, Andresen PA, Avril MF, Azizi E, Scarrà GB, Brown KM, Dębniak T, Elder DE, Friedman E, Ghiorzo P, Gillanders EM, Goldstein AM, Gruis NA, Hansson J, Harland M, Helsing P, Hočevar M, Höiom V; IBD investigators, Ingvar C, Kanetsky PA, Landi MT, Lang J, Lathrop GM, Lubiński J, Mackie RM, Martin NG, Molven A, Montgomery GW, Novaković S, Olsson H, Puig S, Puig-Butille JA; QMEGA and QTWIN Investigators, Radford-Smith GL, Randerson-Moor J; SDH Study Group, van der Stoep N, van Doorn R, Whiteman DC, MacGregor S, Pooley KA, Ward SV, Mann GJ, Amos CI, Pharoah PD, Demenais F, Law MH, Newton Bishop JA, Barrett JH; GenoMEL Consortium.

J Natl Cancer Inst. 2014 Sep 17;106(10). pii: dju267. doi: 10.1093/jnci/dju267. Print 2014 Oct.

PMID:
25231748
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.

Jewell R, Elliott F, Laye J, Nsengimana J, Davies J, Walker C, Conway C, Mitra A, Harland M, Cook MG, Boon A, Storr S, Safuan S, Martin SG, Jirström K, Olsson H, Ingvar C, Lauss M, Bishop T, Jönsson G, Newton-Bishop J.

Pigment Cell Melanoma Res. 2015 Jan;28(1):94-104. doi: 10.1111/pcmr.12315. Epub 2014 Oct 1.

PMID:
25220403
[PubMed - in process]
10.

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.

Nilsson MP, Hartman L, Kristoffersson U, Johannsson OT, Borg A, Henriksson K, Lanke E, Olsson H, Loman N.

Breast Cancer Res Treat. 2014 Oct;147(3):571-8. doi: 10.1007/s10549-014-3115-3. Epub 2014 Sep 4.

PMID:
25187270
[PubMed - in process]
Free PMC Article
11.

Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.

Björner S, Fitzpatrick PA, Li Y, Allred C, Howell A, Ringberg A, Olsson H, Miller CJ, Axelson H, Landberg G.

PLoS One. 2014 Aug 14;9(8):e105099. doi: 10.1371/journal.pone.0105099. eCollection 2014.

PMID:
25122196
[PubMed - in process]
Free PMC Article
12.

Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions.

Barrett JH, Taylor JC, Bright C, Harland M, Dunning AM, Akslen LA, Andresen PA, Avril MF, Azizi E, Bianchi Scarrà G, Brossard M, Brown KM, Dębniak T, Elder DE, Friedman E, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Helsing P, Hočevar M, Höiom V, Ingvar C, Landi MT, Lang J, Lathrop GM, Lubiński J, Mackie RM, Molven A, Novaković S, Olsson H, Puig S, Puig-Butille JA, van der Stoep N, van Doorn R, van Workum W, Goldstein AM, Kanetsky PA, Pharoah PD, Demenais F, Hayward NK, Newton Bishop JA, Bishop DT, Iles MM; GenoMEL Consortium.

Int J Cancer. 2015 Mar 15;136(6):1351-60. doi: 10.1002/ijc.29099. Epub 2014 Aug 14.

PMID:
25077817
[PubMed - in process]
13.

A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging.

Sugihara Y, Végvári A, Welinder C, Jönsson G, Ingvar C, Lundgren L, Olsson H, Breslin T, Wieslander E, Laurell T, Rezeli M, Jansson B, Nishimura T, Fehniger TE, Baldetorp B, Marko-Varga G.

Proteomics. 2014 Sep;14(17-18):1963-70. doi: 10.1002/pmic.201300476. Epub 2014 Aug 18.

PMID:
25044963
[PubMed - in process]
14.

Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case-control study 1988-2009.

Wagner P, Alvegård T, Ranstam J, Rydholm A, Vult von Steyern F, Olsson H.

Cancer Causes Control. 2014 Sep;25(9):1167-77. doi: 10.1007/s10552-014-0420-4. Epub 2014 Jul 18.

PMID:
25034461
[PubMed - in process]
15.

Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass.

Staaf J, Harbst K, Lauss M, Ringnér M, Måsbäck A, Howlin J, Jirström K, Harland M, Zebary A, Palmer JM, Ingvar C, Olsson H, Newton-Bishop J, Hansson J, Hayward N, Gruis N, Jönsson G; Melanoma Genetics Consortium.

J Invest Dermatol. 2014 Dec;134(12):3000-3. doi: 10.1038/jid.2014.272. Epub 2014 Jul 7. No abstract available.

PMID:
24999598
[PubMed - in process]
16.

[Swedish medical research does not need more control].

Andersén P, Bäckström T, Dahlquist G, Damber JE, Engström-Laurent A, Gustafson Y, Hjemdahl P, Korsgren O, Olsson H, Wiberg M, Widmark A.

Lakartidningen. 2014 May 27-Jun 10;111(22-23):980-1. Swedish. No abstract available.

PMID:
24946479
[PubMed - indexed for MEDLINE]
17.

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

Helgadottir H, Höiom V, Jönsson G, Tuominen R, Ingvar C, Borg A, Olsson H, Hansson J.

J Med Genet. 2014 Aug;51(8):545-52. doi: 10.1136/jmedgenet-2014-102320. Epub 2014 Jun 16.

PMID:
24935963
[PubMed - in process]
Free PMC Article
18.

Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden.

Holmes MD, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson TM, Adami HO, Askling J, Smedby KE.

BMC Cancer. 2014 Jun 2;14:391. doi: 10.1186/1471-2407-14-391.

PMID:
24890520
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Sentinel node location in trunk and extremity melanomas: uncommon or multiple lymph drainage does not affect survival.

Gordon D, Smedby KE, Schultz I, Olsson H, Ingvar C, Hansson J, Gillgren P.

Ann Surg Oncol. 2014 Oct;21(11):3386-94. doi: 10.1245/s10434-014-3744-0. Epub 2014 May 28.

PMID:
24866434
[PubMed - in process]
20.

Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line.

Olsson H, Sandström R, Grundemar L.

J Clin Pharmacol. 2014 Nov;54(11):1299-307. doi: 10.1002/jcph.328. Epub 2014 May 21.

PMID:
24800998
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk